Apeiron RIA’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
TA
TWM
FGA
AC
Apeiron RIA's BTAL Position: Q4 2023 in Review
Apeiron RIA sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 10,607 shares — an estimated $211K sold.
Apeiron RIA first reported a position in BTAL in Q3 2022 and held it in 3 quarters. The position peaked at $211K in Q3 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.
- Apeiron RIA reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
- Apeiron RIA sold 10,607 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $211K.
- Apeiron RIA first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 3 quarters.
- Apeiron RIA's AGF US Market Neutral Anti-Beta Fund position peaked at $211K in Q3 2023.
- 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.
Based on Apeiron RIA's 13F filing for Q4 2023, filed 12 Jan 2024.